<DOC>
	<DOCNO>NCT03099785</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy Rifamycin SV-MMX® 600 mg tablet patient diarrhoea-predominant irritable bowel syndrome administer two three time daily .</brief_summary>
	<brief_title>Rifamycin SV-MMX® 600 mg Tablets Administered Three Two Times Daily Patients With IBS-D</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<mesh_term>Rifamycin SV</mesh_term>
	<criteria>1 . Informed Consent : sign write informed consent inclusion study 2 . Sex Age : males/females , ≥18 year old 3 . IBS Diagnosis : confirm IBSD diagnosis per Rome IV criteria 4 . Symptoms : active symptom IBS baseline ( day 1 ) measure average daily score least 7 day baseline : 1. abdominal pain score ≥3 use 11point numeric rating scale 2. bloat score : 24 inclusive 3. stool consistency : score 6 7 ( measure Bristol stool form scale ) least 2 day day 7 day 1 negative response global IBS symptom assessment question IBSrelated bloat assessment question give weekly screen phase day 1 randomisation : 4 . `` In past 7 day , adequate relief IBS symptom ? '' [ No ] 5 . `` In past 7 day , adequate relief IBS symptom bloating ? `` [ No ] 5 . Colonoscopy : perform within 5 year ; patient 's age &gt; 50 , colonoscopy perform within 2 year 6 . Full comprehension : ability comprehend full nature purpose study , include possible risk side effect ; ability cooperate investigator comply requirement study 7 . Literacy : sufficiently literate comply study requirement use electronic diary fill electronic form 8 . Contraception fertility : female childbearing potential fertile male must use least one reliable method contraception . Reliable method contraception woman include : 1 . Hormonal oral , implantable , transdermal , injectable contraceptive least 2 month screen visit 2 . A nonhormonal intrauterine device [ IUD ] female condom spermicide contraceptive sponge spermicide diaphragm spermicide cervical cap spermicide least 2 month screen visit Reliable method contraception men male partner female patient include : 3 . Male condom spermicide Reliable method contraception woman men include : 4 . A sterile sexual partner sexual abstinence Women nonchildbearing potential postmenopausal status least 1 year sterile surgically sterilise men admit . For woman childbearing potential , serum pregnancy test result must negative screen 1 . IBS : symptom constipation baseline : 1. less 3 bowel movement week 2. stool consistency score ≤2 ≥2 day week 2 . Screening phase : failure record daily symptom assessment diary card least 7 day baseline 3 . Gastroenteric : underlying gastrointestinal disease include ulcerative colitis , Crohn 's disease , pancreatitis , active infectious , haemorrhagic inflammatory disorder relate IBSD , gastrointestinal motility disorder ileus , gastroparesis pseudoobstruction , gastroduodenal ulcer , gastrointestinal malignancy potentially fatal disease full remission ( 5 year diagnosis without maintenance treatment ) , amyloidosis cholelithiasis cholecystectomy perform 4 . Intolerance : ascertain underlie lactose intolerance response diet malabsorption syndrome exclusion asymptomatic lactose malabsorption 5 . Coeliac disease : ascertain presumptive underlying coeliac disease 6 . Bile : ascertain presumptive bile acid malabsorption bile acid induce diarrhoea 7 . Diabetes : underlie diabetes type I II 8 . Thyroid : abnormal thyroid function control thyroid medication 9 . Allergy : ascertain presumptive hypersensitivity active principle and/or formulation ' ingredient ; history anaphylaxis drug allergic reaction general , investigator considers may affect outcome study 10 . Renal function : ascertain presumptive clinically significant renal insufficiency creatinine twice upper limit normal ( ULN ) perform laboratory reference range 11 . Liver function : chronic liver disease clinically significant liver enzyme abnormality evidence elevate AST , ALT total bilirubin &gt; 1.5 time ULN 12 . AIDS/HIV : ascertain presumptive acquire immunodeficiency ( AIDS ) know infection human immunodeficiency virus ( HIV ) 13 . Diseases : significant history medical surgical condition exclude hysterectomy , caesarean section , appendectomy , cholecystectomy , benign polypectomy inguinal hernia include renal , hepatic , cardiovascular , haematological , endocrine , immune , psychiatric neurological disease investigator 's opinion may interfere aim study ; malignant disease remission least 5 year 14 . Medications : alosetron , eluxadoline , ondansetron , tegaserod , lubiprostone , warfarin , antipsychotic , antispasmodic , prokinetic , antidiarrhoeal , laxative , probiotic , narcotic antibiotic agent within 14 day screen visit ; antidepressant agent selective serotoninreuptake inhibitor tricyclic class unless take stable dose least 6 week screen visit 15 . Investigational drug : participation evaluation investigational product within 30 day study 16 . Drug alcohol : known history drug alcohol [ &gt; 1 drink/day female &gt; 2 drinks/day male , define accord USDA Dietary Guidelines 2015 ] abuse 17 . Pregnancy ( female ) : pregnant lactate woman wish become pregnant 3 month follow visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>